Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…fully affect dose–volume distributions and downstream toxicity. Head and neck cancer is particularly sensitive to subtle dosimetric differences. Sma…
…formed cancer therapy; however, response rates remain modest in head and neck cancer (HNCa) patients. 1–4 While many studies focus on manipulating i…
…ovascular embolization is frequently performed in patients with head and neck cancer for hemorrhage control and tumor-related vascular management. H…
…s (RICAS) is an increasingly recognized late complication among head and neck cancer survivors. Carotid artery stenting (CAS) is often favored over …
…ty of escalating LETd to the tumour using multi-ion therapy for head and neck cancer, with the secondary goal of identifying the maximum tolerated L…
… improved standardisation, their impact on clinical outcomes in head and neck cancer remains indirect. In head and neck radiotherapy, long-term toxi…
…ead and neck cancer (RR 21.31 (95% CI 4.32 to 105.14), I2=97%), liver cancer (RR 4.07 (95% CI 2.34 to 7.08), I2=94%), cervical cancer (RR 3.…
… identify novel potential mediators, including LoF of TGFBR2 in NSCLC, CYLD in head and neck cancer, and RUNX1 in triple-negative bre…
…ing, is a common and debilitating toxicity affecting 23%–28% of head and neck cancer (HNC) survivors treated with radiotherapy. Beyond its classific…
…with melanoma, 100 with non-small-cell lung cancer, and 11 with renal cancer. Reduced dose pembrolizumab was prescribed in 82% (192 out of 2…
…ageal cancer, 10 with gastric cancer, 39 with melanoma, 45 with non-small-cell lung cancer, 41 with renal cancer, seven with urothelial bladder cancer, an…
…Objective Autoimmune rheumatic diseases, including rheumatoid arthritis (RA), have recently been associated with an increased risk of c…